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Abstract
AIM: To assess and correlate the lipid content of vari-
ous organs in obese subjects and in persons with a 
normal body weight.
METHODS: Magnetic resonance spectroscopy and a 
previously validated gradient echo magnetic resonance 
imaging method with Dixon’s two point technique were 
used in this study to quantify fat in liver, pancreas as 
well as kidney. 
RESULTS: In 36 volunteers with body mass index (BMI) 
ranging from 20.0 to 42.9 kg/m2, the median fat content 
of liver, pancreas and kidney was 2.3% (interquartile 
range: 0.2%-7.8%), 2.7% (1.0%-6.5%) and 0.7% 
(0.1%-1.4%), respectively. BMI and subcutaneous 
fat correlated significantly with liver and pancreas fat 
content. We show for the first time the significant 
correlation of liver and pancreas fat content in healthy 
controls (r  = 0.43, P  < 0.01). These observations are 
related to body weight as measured by BMI and the 
amount of subcutaneous fat. Kidney fat content is very 
low and correlates with none of the other fat depots.
CONCLUSION: Renal lipid accumulation, unlike the 
coupled accumulations of fat in liver and pancreas, is 
not observed in obese subjects. Unlike suggestions 
made in previous studies, renal lipid accumulation ap-
pears not to be involved in the pathogenesis of renal 
disease in humans.
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
Storage of  fat within the peritoneal cavity (visceral fat) and 
within other tissues (ectopic fat) rather than in subcutane-
ous adipocytes, is accompanied by adverse metabolic and 
lipotoxic effects[1,2]. Both visceral fat[1] and liver fat[3] are 
known for secreting numerous atherogenic factors into 
the blood system, e.g. lipids and inflammatory cytokines, 
predisposing to cardiovascular diseases, one of  which is 
atherosclerotic renovascular disease (ARVD)[4,5]. It has 
been hypothesized that in obesity and metabolic syn-
drome, ectopic fat causes lipotoxic damage to organs[4,5], 
e.g. liver (steatohepatitis and cirrhosis)[6], pancreas (β-cell 
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dysfunction)[7] and lipotoxicity of  the kidney[4]. 
Whereas liver steatosis has been quantified in doz-
ens of  magnetic resonance imaging (MRI) studies, and 
pancreatic lipomatosis[8-10] and muscle fattening[8-11] in 
some, quantitative documentation of  the content of  fat 
in human kidneys in situ appears to be lacking entirely. In 
rats, however, steatosis of  the kidney was recently asso-
ciated with an alteration in renal acidification[12]. In that 
study, the fat accumulated in the renal cortex, as shown 
quantitatively by enzymatic triglyceride measurement and 
qualitatively by oil red O staining[12]. This fits the notion 
that, within the cortex, the proximal tubule is vulnerable 
to lipid accumulation due to its role in the reabsorption 
of  free fatty acids bearing albumin[13,14]. 
The most accurate, and therefore preferable, method 
for quantifying hepatic fat content is metabolic MRI, i.e. 
multivoxel magnetic resonance spectroscopy (MRS)[15-17]. 
Other MRI methods are less reproducible or have sys-
tematic errors. In a previously published comparison of  
subjects examined by MRS and by a Dixon-based dual-
echo breath hold gradient echo method, we found strong 
correlation between the liver fat content according to 
both methods and concluded that MRI can be used for 
quantifying fat content, provided that the small system-
atic overestimation of  fat content at the lower end range 
is corrected for[17]. The comparison is now extended to 
36 volunteers, varying from lean to obese, with applica-
tion of  the Dixon-based MRI fat quantification method 
to pancreas and kidney as well as liver. Only the liver was 
additionally examined by MRS. Our approach was to ap-
ply the equation converting the liver MRI fat values to 
the MRS values, to the pancreas and kidney MRI values. 
Additional MRS examinations of  pancreas and kidney 
would have made the total MRI examination times too 
lengthy. Furthermore, reliable MRS of  the renal cortex, 
a thin layer of  tissue sandwiched between the peripheral 
fat and the fatty core of  the kidney, is technically not 
feasible. 
High hepatic lipid content is common in obese sub-
jects who are otherwise healthy, i.e. overweight persons 
not suffering from metabolic disease[15]. In this study we 
examined 36 volunteers with a wide range of  body mass 
index (BMI) values, using previously validated MRI meth-
ods to quantify the fat content of  liver, pancreas as well as 
kidney. The purpose was to quantify the lipid content of  
these organs in obese subjects and in persons with a nor-
mal body weight. Our hypothesis was that in obese per-
sons the lipid content of  liver, pancreas and kidney would 
be higher than in thin persons. Our comparatively large 
study was also intended to assess possible relationships 
between the fat content in different organs. 
MATERIALS AND METHODS
Thirty-six adult volunteers were recruited by adverti-
sement to undergo abdominal MRI and liver MRS. These 
volunteers had a BMI ranging from 20.0 to 42.9 kg/m2 
with a mean value of  27.5 kg/m2 and were average in that 
they were neither profound exercisers nor sedentary. Eight 
out of  36 subjects were obese, i.e. they had BMI values 
exceeding a value of  30. Two-thirds of  the participants 
were men; the median age was 39 years (range: 22-64 
years). Everyone was interviewed to assess the status of  
his health and cases of  any disease, including diabetes, 
were excluded. All volunteers gave informed consent. The 
studies were approved by the medical ethics committee. 
Magnetic resonance studies 
MRI and MRS studies took place in one measurement 
session, using a 1.5 Tesla whole-body scanner (MAGN-
ETOM Avanto; Siemens Medical Solutions, Erlangen, 
Germany) equipped with gradients of  up to 40 mTm-1 
(maximal slew rate = 200 mT m-1/ms) and a six-channel 
spine array coil. Subjects were in the supine position. 
In both MRI and MRS a large flex coil placed over the 
liver was used simultaneously with the spine array coil as 
receiver. T1-weighted gradient echo images were recorded 
to assess the anatomy of  liver, kidneys and pancreas. 
Dixon’s two point MRI technique 
Breath-hold T1-weighted gradient echo MR images, a dual 
flip angle adaptation of  the wide spread gradient-recalled 
echo MRI method based on Dixon’s two point technique[18], 
were acquired with 6 mm slice thickness, section gap 0 mm, 
matrix 256 × 160 and a repetition time (TR) of  155 ms, 
and TEs of  2.4 ms (OP) and 4.8 ms (IP). Flip angles of  20o 
and 70o were used to generate intermediate-weighted and 
T1-weighted images, respectively. Images were corrected for 
T2* decay: Scorrected = Se(τ/T2*), where τ is the echo time differ-
ence between IP and OP images, and S represents the sig-
nal intensity in a defined region of  interest (ROI)[19]. Under 
these conditions τ = 2.4 ms combined with T2* = 19.44, 
calculated from the mean spectral line width of  the water 
peak in human liver measured by MRS in the 36 volunteers 
(details are given in a next paragraph), gave a correction 
factor of  1.13 for Sip relative to Sop. 
The algorithm used for estimating fat content, modi-
fied to prevent occasional mix-ups of  water and fat 
signals[17], consists of: (a) adjustment for T2* relaxation 
as described above, (b) calculation of  the apparent 
fat content using the following equation %fat = (SIP - 
SOP)/2SIP × 100% (equation 1) for both intermediate- 
or hydrogen density-weighted, (%fatHwt at 20o flip angle) 
and T1-weighted (%fatT1wt at 70o flip angle) image pairs, 
(c) if  fatHwt AND %fatT1wt ≤ 20%, then %fat = MIN 
[%fatHwt, %fatT1wt], if  fatHwt AND %fatT1wt > 20% and 
%fatHwt ≤ %fatT1wt, then %fat = %fatHwt, otherwise, %fat 
= 100% - %fatHwt, where AND is a logical operator, and 
MIN (a, b) is a mathematical operator computing the 
minimum value between a and b. A T2* of  19.4 ms for 
liver tissue was adopted from the results of  a previous 
study[17] for correcting Sip in the above mentioned MRI 
algorithm. This value was used for correcting all MRI fat 
content figures in Table 1. 
Liver MRS for correcting abdominal MRIs 
Hybrid 2D-spectroscopic imaging (chemical shift imaging, 
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CSI), point resolved spectroscopy (PRESS) with a rep-
etition time (TR) of  5000 ms and an echo time (TE) of  
30 ms, was performed using a field of  view of  16 × 16 
cm2 and a volume of  interest of  5 × 8 × 4 cm3 positioned 
inside the liver (Figure 1C)[20]. The CSI measurement 
lasted 16 × 16 × 5 = 1280 s or approximately 21 min. 
Shimming was automated and water suppression was not 
applied in order to be able to calculate the fat-water ratio 
distributions in the liver directly[17]. At the used TR of  5 s, 
T1 saturation of  the water and fat signals is negligible, that 
is TR > 5T1[21], and at the used TE of  30 ms the correc-
tion applied to our data to compensate for the fact that 
the fat signal has a longer T2 (78 ms) than water (60 ms) 
was 12.2%[22]. In our MRS method respiratory compensa-
tion was not applied as this was previously shown not to 
affect the quality and composition of  our liver spectra[17]. 
The liver MRS data were co-registered to the MR 
images in the liver by using the coordinates of  the an-
terior right (AR) and posterior left (PL) at the same 
height position as regional checkpoints. The kidney and 
pancreas MRI fat contents were derived from a single 
slice centered on the organ involved. Figure 1 shows 
the regions of  interest for kidney (a), pancreas and liver 
tissue (b) and the matching liver MRS spectral map (c) 
for one of  the volunteers examined. In the analysis of  
kidney data the results for left and right kidney volumes 
of  interest containing medulla and renal column tissue 
were averaged. MRS measurements of  the renal cortex 
and pancreas were not performed because, apart from 
measurement time considerations, accurate quantifica-
tion of  small tissue volumes adjacent to the fatty tissue 
surrounding these organs is impossible.
The thickness of  the layer of  subcutaneous fat was 
measured at the two most left and right points on the 
same MRI slice to obtain a measure of  the amount of  
subcutaneous fat tissue (Figure 1A). A more precise 
method[23] was not feasible in our study, as the MRI field 
of  view was often too small to depict the entire abdomi-
nal body cross section.
The pancreas measurements were confined to the 
tail (cauda) because that tended to be easier to depict 
than caput and corpus (Figure 1B). The difference be-
tween the liver fat content according to MRS, the gold 
standard[17], and liver fat content according to MRI was 
used to correct all MRI content figures determined in 
this study (kidney, liver, pancreas). This approach is rea-
sonable because with the combined use of  the flex and 
spine array as receiver MRI coils, the B1 field in the po-
sitions corresponding with the locations of  these organs 
did not show significant differences. In other words, the 
outcome of  phantom experiments gave us reason to 
expect that equivalent Dixon’s two point technique MRI 
signal intensities in liver, pancreas and kidney should 
correspond to the same fat content.
Statistical analysis
The distributions of  the obtained fat contents were not 
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Table 1  Spearman’s correlation coefficients (r s) between 
measures of obesity, and MRI fat measurements according to 
Dixon’s two point technique in kidney, liver and pancreas after 
correction by MRS
n = 36 Correlation
BMI Subc.fat Kidney fat Liver fat Pancreas fat
BMI -  0.765b 0.264  0.517b  0.349a
Subcutaneous
Fat (cm)  0.765b - 0.256  0.447b  0.442b
Liver fat  (%)  0.517b  0.447b 0.231 -  0.428b
Pancreas fat (%)  0.349a  0.442b 0.081  0.428b -
Kidney fat (%) 0.264 0.256 - 0.231 0.081
aP < 0.05, bP < 0.01. MRI: Magnetic resonance imaging; MRS: Magnetic 
resonance spectroscopy; BMI: Body mass index.
Figure 1  Regions of interest on magnetic resonance imaging (MRI) (OP 
series with 70º pulse angle and TE = 2.4 ms) and the corresponding 
magnetic resonance spectroscopy (MRS). A: Kidney and subcutaneous 
tissue measurement; B: Liver and pancreas; C: Liver MRS spectral map, 
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normal, thus non-parametric correlations were calculated 
using Spearman’s correlation coefficients (with 2-tailed 
testing of  significance). 
RESULTS
MRI correction 
Mean liver fat content according to MRS was 3.2% lower 
than that according to MRI (4.4% vs 7.6%). The linear 
correlation between liver fat content according to MRI 
and MRS is shown in Figure 2 (r = 0.95, P < 0.0001). The 
obtained slope (y = 1.216x - 4.82) was used to correct all 
MRI-determined tissue fat contents.
MRI fat measurements 
After correction for this systematic overestimation, which 
is inherent to the MRI method[13], calculated fat content of  
liver, pancreas and kidney was 2.3% (interquartile range: 
0.2%-7.8%), 2.7% (1.0%-6.5%) and 0.7% (0.1%-1.4%), 
respectively. For the kidney fat measurements the variance 
between subjects was lower (interquartile range: 1.8%) 
than in liver (7.6%) and pancreas (5.5%). Illustrated 
by Figure 3 is the observation that, compared with the 
normal body weight subjects, the subgroup of  obese 
subjects tended to have comparatively high fat in the liver 
(median 4.57% vs 1.11%), slight elevation in the pancreas 
(3.60% vs 2.26%) and equally low fat contents in the 
kidney (1.35 vs 0.64). The interquartile ranges for these 
organs in obese and normal weight persons showed great 
overlap and were  of  comparable magnitude, i.e. 2.93-7.70 
(0.18-7.76), 2.32-8.88 (0.62-5.45) and 0.61-1.49 (0.10-1.17), 
respectively. Table 1 shows that BMI, a measure of  overall 
fat deposits in the human body, correlated significantly 
with the amount of  subcutaneous fat (r = 0.77, P < 0.01), 
liver fat content (r = 0.52, P < 0.01) and pancreas fat 
content (r = 0.35, P < 0.05). The amount of  subcutaneous 
fat also correlated significantly with liver fat content and 
pancreas fat content (r = 0.45 and r = 0.44, respectively; 
P < 0.01). Liver and pancreas fat contents were signi-
ficantly correlated (r = 0.43, P < 0.01). Kidney fat content 
was comparatively low, showed little intersubject variation 
and correlated with none of  the other fat depots. 
DISCUSSION
These healthy volunteers, who varied in body weight 
from lean to obese, had kidney fat contents that were 
comparatively low and showed little variation between 
subjects. The kidney fat content correlated with none of  
the other fat depots, indicating that in otherwise healthy 
subjects obesity does not affect kidney fat content. In 
other words, renal lipid accumulation, unlike the accu-
mulation of  fat in liver and pancreas, is not observed in 
obese healthy subjects. 
In this study, we used a previously validated gradient 
echo MRI method[17] for determining the fat content in 
liver pancreas and kidney. In our liver measurements we 
compared the MR spectroscopy results in the thirty-six 
volunteers with the MRI liver content results to refine the 
correction equation needed to adapt the MRI method for 
quantitative use. Specifically, we determined the coefficient 
of  correlation between the two-point Dixon-based MRI 
method and the MRS results in liver and used the result 
to correct all MRI data for systematic overestimation 
at the lower end range, a phenomenon also observed 
by others[24] and most probably related to Rician noise 
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Figure 3  Tissue fat content, median values and interquartile ranges, accord­
ing to MRI (i.e. after correction by MRS) for subjects with normal body 
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Figure 2  Liver fat content according to MRS plotted against the fat 
content of the same volume of interest according to MRI.
y = 1.216x - 4.8186
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distribution-related overestimation of  the magnitude 
images of  weak fat signals. Thus we have used our liver 
data for correcting all MRI data based on the assumption 
that the MRI method works out the same for liver and 
other organs (pancreas, kidney). This is the best one can 
do, considering that (1) MRS examinations of  small fat 
embedded organs are inaccurate; and that (2) it is not an 
option to collect tissue biopsies from healthy volunteers. 
Furthermore, as stated in Materials and Methods, control 
experiments had made sure that with the radiofrequency 
coils used, the MRI signal intensities in positions corre-
sponding with those of  liver, pancreas and kidney corre-
sponded to the same fat contents.
Renal lipotoxicity and its role in the pathogenesis 
of  renal disease are not fully understood[4,5]. It has been 
assumed that renal disease progression is promoted by 
the accumulation of  lipids in the kidneys, a phenomenon 
in which triglyceride-rich lipoproteins, free fatty acids 
and their metabolites, and albumin-loaded free fatty acids 
appear to be involved. Quantitative documentation of  
the content of  fat in human kidneys in situ appears not to 
exist, so we cannot compare our MRI-determined kidney 
fat content figures to literature data. In a bovine growth 
hormone transgenic mouse line, kidney triglycerides, while 
lower than those found in liver, recently showed a similar 
trend of  reduced levels as compared with non-transgenic 
littermate controls showing overall fat mass increases[25]. 
Furthermore, in rats, steatosis of  the kidney was recently 
associated with an alteration in renal acidification[12]. The 
fat accumulated in the renal cortex, as shown quantitative-
ly by enzymatic triglyceride measurement and qualitatively 
by oil red O staining[12]. This fits the notion that, within 
the cortex, the proximal tubule is vulnerable to lipid ac-
cumulation due to its role in the reabsorption of  free fatty 
acids bearing albumin[13,14]. Our result in humans, with 
regard to the finding of  very low fat content (up to 2%) in 
the cortex of  kidneys of  both lean and obese individuals, 
is not in line with the findings of  the above experimental 
studies. 
Our observation of  significant correlation between 
liver and pancreas fat content according to MRI (r = 0.43, 
P < 0.01) is also in disagreement with a recent study in-
volving a smaller number of  volunteers than we included 
here (17 vs 36)[10], and with another small study (n = 15) 
in which the existence of  significant correlation between 
liver and pancreas fat content is not mentioned[8]. The 
small scale of  both earlier studies in humans probably ex-
plains their failure to demonstrate the correlation between 
the fat content in liver and pancreas. The presence of  
such a correlation does fit a previous demonstration that 
obese nondiabetic subjects have increased fat in the pan-
creas[8]. It is also in line with a notion that lipomatosis of  
the pancreas reflects early events in the pathogenesis of  
diabetes[9], confirming what has been shown in numerous 
publications dealing with the fattening of  the liver. 
The significant correlations of  BMI with both liver 
and pancreas fat content in this study are in agreement 
with a previous report[8]. Why would obese subjects 
tend to accumulate fat in liver and pancreas and not 
in the kidney, despite the observation that obesity and 
the metabolic syndrome are involved with initiation of  
chronic kidney disease[4]? It seems that due to specific re-
quirements, such as albumin loading needed to facilitate 
the uptake of  fat into kidney tissue, obese but otherwise 
healthy subjects do not accumulate fat in the kidneys. 
In conclusion, this is the first demonstration of  the use 
of  an MRI method for determining kidney fat content. 
Observed for the first time are significantly correlated 
liver and pancreas fat contents in (otherwise) healthy 
persons varying in body weight from lean to obese. These 
observations are related to body weight as measured by 
BMI and the amount of  subcutaneous fat. The amount 
of  fat in the kidney in obese persons is small and not re-
lated to the amount of  body fat or the fat content of  liver 
and pancreas. We have thus shown that in obesity, the 
first step in the pathogenesis of  renal disease, lipid is not 
accumulated in the kidney. Therefore, the role of  lipid ac-
cumulation in the pathogenesis of  renal disease, diabetes 
and metabolic disease in humans should be reconsidered. 
That is not to say that fat metabolites, rather than the tri-
glyceride levels detected here by MRI, may have profound 
effects. In future studies we propose to examine patients 
suffering from the above illnesses in order to validate our 




Worldwide obesity is on the rise and so are diseases associated with accumula-
tion of fat in various organs.
Research frontiers
This is the first study providing quantitative fat content data for human liver, 
pancreas and kidney in situ.
Innovations and breakthroughs
Shown here for the first time is significant correlation of the liver and pancreas 
fat contents in persons with body weights varying between thin and obese.
Applications 
This study shows that magnetic resonance imaging can be used to study 
metabolic disease noninvasively. The fat content of multiple organs can thus be 
quantified and correlated.
Terminology
The fat content of human tissues can be quantified by using magnetic reso-
nance imaging methods to quantify and compare the signals of water and fat. 
The fat content of human tissues is typically expressed as fat/(water+fat).
Peer review
The study assessed renal lipid accumulation, as well as fat accumulation in the 
liver and pancreas of a series of volunteers varying in body weight from thin to 
obese. Results confirmed the correlation between liver and subcutaneous fat 
content as well as showing the absence of fat storage in the kidney. The latter 
is the real novel finding of the study.
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